Cue Biopharma at Festival of Biologics 2026

Oct 13–15, 2026 Basel, Switzerland ~3k attendees Website

Cue Biopharma takes part in 2 sessions at Festival of Biologics 2026 in Basel. Its program centres on engineered proteins that deliver the immune signal IL-2 to chosen T cells. Topics include engagers that send IL-2 only to tumor-specific T cells and CUE-401, a fusion protein that creates and expands regulatory T cells, which calm the immune system, for autoimmune disease.

OrganizationFestival of Biologics 2026 Attendance
Cue Biopharma
Boston, MA
Talk
Wed Oct 14
11:30
TCR-Specific Engagers that Selectively Target IL-2 to Tumor-Specific T Cells
Bispecifics & Multispecifics
Talk
Thu Oct 15
11:20
CUE-401: A Novel IL-2/TGF-beta Fusion Protein for the Induction & Expansion of FOXP3+ Regulatory T Cells
Disease Areas: Inflammation & Autoimmune

Explore the full Festival of Biologics 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Basel. Leave your work email and we’ll be in touch.

Privacy

Download the full Festival of Biologics 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Cue Biopharma

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Terrapinn or the Festival of Biologics. Submit a correction